| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiration | 38 | 2024 | 267 | 9.930 |
Why?
|
| Respiratory Center | 27 | 2025 | 55 | 6.360 |
Why?
|
| Neurons | 43 | 2025 | 1591 | 5.800 |
Why?
|
| Nerve Net | 34 | 2021 | 375 | 5.360 |
Why?
|
| Respiratory Insufficiency | 8 | 2024 | 162 | 4.520 |
Why?
|
| Medulla Oblongata | 16 | 2024 | 93 | 4.060 |
Why?
|
| Respiratory Mechanics | 19 | 2014 | 102 | 3.860 |
Why?
|
| Periodicity | 17 | 2019 | 119 | 3.650 |
Why?
|
| Brain Stem | 18 | 2024 | 167 | 3.160 |
Why?
|
| Hypoxia | 18 | 2024 | 657 | 3.160 |
Why?
|
| Rett Syndrome | 8 | 2022 | 19 | 2.790 |
Why?
|
| Models, Neurological | 10 | 2025 | 412 | 2.700 |
Why?
|
| Analgesics, Opioid | 6 | 2024 | 451 | 2.620 |
Why?
|
| Biological Clocks | 14 | 2011 | 74 | 2.450 |
Why?
|
| Synaptic Transmission | 15 | 2022 | 228 | 2.250 |
Why?
|
| Mice | 70 | 2025 | 11858 | 2.050 |
Why?
|
| Sudden Infant Death | 3 | 2024 | 27 | 2.050 |
Why?
|
| Animals | 92 | 2025 | 27536 | 1.990 |
Why?
|
| Action Potentials | 23 | 2025 | 601 | 1.980 |
Why?
|
| Deglutition | 3 | 2024 | 77 | 1.900 |
Why?
|
| Inhalation | 5 | 2021 | 31 | 1.760 |
Why?
|
| Autonomic Nervous System Diseases | 4 | 2023 | 22 | 1.690 |
Why?
|
| Arousal | 6 | 2022 | 170 | 1.670 |
Why?
|
| Respiration Disorders | 4 | 2022 | 41 | 1.440 |
Why?
|
| Neuronal Plasticity | 8 | 2018 | 194 | 1.310 |
Why?
|
| Neural Inhibition | 8 | 2018 | 97 | 1.280 |
Why?
|
| Respiratory Physiological Phenomena | 4 | 2014 | 48 | 1.180 |
Why?
|
| Optogenetics | 3 | 2024 | 37 | 1.160 |
Why?
|
| Respiratory System | 8 | 2023 | 117 | 1.150 |
Why?
|
| Interneurons | 5 | 2024 | 94 | 1.130 |
Why?
|
| Mice, Transgenic | 13 | 2025 | 1579 | 1.100 |
Why?
|
| Central Nervous System | 4 | 2018 | 153 | 1.090 |
Why?
|
| Larynx | 2 | 2023 | 37 | 1.050 |
Why?
|
| Calcium | 6 | 2023 | 1179 | 1.050 |
Why?
|
| Mice, Inbred C57BL | 16 | 2025 | 3253 | 1.050 |
Why?
|
| Neuroglia | 3 | 2023 | 105 | 1.040 |
Why?
|
| Motor Neurons | 5 | 2022 | 176 | 1.040 |
Why?
|
| Sodium | 3 | 2025 | 333 | 0.990 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 2025 | 80 | 0.990 |
Why?
|
| Dependovirus | 2 | 2024 | 34 | 0.980 |
Why?
|
| Animals, Newborn | 19 | 2021 | 524 | 0.970 |
Why?
|
| Rabies virus | 1 | 2024 | 6 | 0.970 |
Why?
|
| In Vitro Techniques | 23 | 2014 | 996 | 0.960 |
Why?
|
| Neocortex | 6 | 2012 | 96 | 0.960 |
Why?
|
| Efferent Pathways | 1 | 2024 | 22 | 0.950 |
Why?
|
| Central Pattern Generators | 2 | 2021 | 4 | 0.900 |
Why?
|
| Whole Genome Sequencing | 1 | 2024 | 103 | 0.880 |
Why?
|
| Autonomic Nervous System | 3 | 2023 | 65 | 0.880 |
Why?
|
| Oligodendroglia | 1 | 2024 | 124 | 0.870 |
Why?
|
| Mammals | 3 | 2018 | 237 | 0.830 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 51 | 0.820 |
Why?
|
| Morphine | 1 | 2023 | 130 | 0.820 |
Why?
|
| Neurotransmitter Agents | 3 | 2019 | 108 | 0.800 |
Why?
|
| Sneezing | 1 | 2022 | 36 | 0.790 |
Why?
|
| Oxygen | 5 | 2018 | 746 | 0.770 |
Why?
|
| Receptors, Opioid, mu | 1 | 2021 | 45 | 0.760 |
Why?
|
| Patch-Clamp Techniques | 14 | 2025 | 397 | 0.750 |
Why?
|
| Brain | 6 | 2022 | 2306 | 0.740 |
Why?
|
| Hypoxia, Brain | 4 | 2018 | 43 | 0.710 |
Why?
|
| Neurophysiology | 1 | 2020 | 14 | 0.700 |
Why?
|
| Oxygen Consumption | 3 | 2010 | 245 | 0.700 |
Why?
|
| Sodium Channels | 7 | 2012 | 130 | 0.680 |
Why?
|
| Editorial Policies | 1 | 2020 | 34 | 0.680 |
Why?
|
| Neural Pathways | 4 | 2016 | 319 | 0.680 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 332 | 0.680 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2024 | 218 | 0.660 |
Why?
|
| Transcriptome | 2 | 2024 | 661 | 0.660 |
Why?
|
| Substance P | 5 | 2019 | 61 | 0.650 |
Why?
|
| Periodicals as Topic | 1 | 2020 | 168 | 0.590 |
Why?
|
| Opioid-Related Disorders | 1 | 2021 | 193 | 0.590 |
Why?
|
| Calcium Channels | 4 | 2007 | 182 | 0.590 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2024 | 2360 | 0.580 |
Why?
|
| Synapses | 5 | 2016 | 280 | 0.570 |
Why?
|
| Male | 38 | 2025 | 42705 | 0.560 |
Why?
|
| Ion Channels | 4 | 2017 | 246 | 0.560 |
Why?
|
| Humans | 40 | 2024 | 90014 | 0.540 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 3 | 2024 | 6 | 0.540 |
Why?
|
| Dentate Gyrus | 4 | 2021 | 32 | 0.530 |
Why?
|
| Carbon Dioxide | 1 | 2017 | 201 | 0.530 |
Why?
|
| Respiratory Burst | 3 | 2006 | 18 | 0.530 |
Why?
|
| Hippocampus | 2 | 2011 | 449 | 0.510 |
Why?
|
| Pulmonary Ventilation | 2 | 2013 | 33 | 0.500 |
Why?
|
| Disease Models, Animal | 7 | 2024 | 2395 | 0.490 |
Why?
|
| Substantia Nigra | 3 | 2025 | 29 | 0.490 |
Why?
|
| Dinoprostone | 2 | 2014 | 70 | 0.480 |
Why?
|
| Female | 33 | 2024 | 46617 | 0.470 |
Why?
|
| Lip | 1 | 2014 | 16 | 0.470 |
Why?
|
| Organ Culture Techniques | 7 | 2021 | 135 | 0.460 |
Why?
|
| Seizures | 3 | 2022 | 307 | 0.450 |
Why?
|
| Calcium Channels, N-Type | 1 | 2013 | 17 | 0.420 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2013 | 36 | 0.420 |
Why?
|
| Polysomnography | 3 | 2013 | 151 | 0.420 |
Why?
|
| Norepinephrine | 3 | 2014 | 172 | 0.420 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 177 | 0.410 |
Why?
|
| Hyperthermia, Induced | 2 | 2004 | 73 | 0.410 |
Why?
|
| Sex Characteristics | 2 | 2020 | 328 | 0.400 |
Why?
|
| Neurogenesis | 4 | 2018 | 77 | 0.390 |
Why?
|
| Pyramidal Cells | 4 | 2016 | 81 | 0.380 |
Why?
|
| Invertebrates | 1 | 2011 | 33 | 0.380 |
Why?
|
| Oxidants | 1 | 2011 | 86 | 0.370 |
Why?
|
| Lung Diseases | 1 | 2013 | 275 | 0.370 |
Why?
|
| Adaptation, Physiological | 3 | 2008 | 318 | 0.370 |
Why?
|
| Cholinergic Neurons | 2 | 2024 | 9 | 0.370 |
Why?
|
| Tetrodotoxin | 7 | 2012 | 50 | 0.370 |
Why?
|
| Infant, Premature | 1 | 2013 | 299 | 0.370 |
Why?
|
| Hydrogen Peroxide | 1 | 2011 | 158 | 0.360 |
Why?
|
| Vertebrates | 1 | 2011 | 105 | 0.350 |
Why?
|
| Isoflurane | 2 | 2024 | 64 | 0.350 |
Why?
|
| Leigh Disease | 2 | 2024 | 3 | 0.350 |
Why?
|
| Anesthetics, Inhalation | 2 | 2024 | 97 | 0.340 |
Why?
|
| Flufenamic Acid | 6 | 2014 | 13 | 0.330 |
Why?
|
| Excitatory Postsynaptic Potentials | 5 | 2018 | 88 | 0.330 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 4 | 2020 | 17 | 0.330 |
Why?
|
| Seals, Earless | 1 | 2008 | 1 | 0.320 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2008 | 27 | 0.320 |
Why?
|
| Mice, Knockout | 6 | 2024 | 2016 | 0.310 |
Why?
|
| Behavior, Animal | 1 | 2011 | 381 | 0.310 |
Why?
|
| Dopaminergic Neurons | 2 | 2025 | 26 | 0.300 |
Why?
|
| Riluzole | 5 | 2014 | 15 | 0.290 |
Why?
|
| Homeostasis | 3 | 2018 | 418 | 0.290 |
Why?
|
| Epilepsy | 3 | 2022 | 424 | 0.280 |
Why?
|
| Wakefulness | 2 | 2012 | 135 | 0.280 |
Why?
|
| Biophysics | 3 | 2019 | 153 | 0.270 |
Why?
|
| Heart Rate | 3 | 2012 | 498 | 0.270 |
Why?
|
| Respiratory Rate | 3 | 2023 | 20 | 0.270 |
Why?
|
| Electric Stimulation | 5 | 2011 | 365 | 0.260 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 4 | 2012 | 87 | 0.260 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2006 | 51 | 0.250 |
Why?
|
| Electron Transport Complex I | 4 | 2024 | 31 | 0.250 |
Why?
|
| Parkinson Disease | 2 | 2025 | 151 | 0.240 |
Why?
|
| Neuroanatomical Tract-Tracing Techniques | 1 | 2024 | 2 | 0.240 |
Why?
|
| Levodopa | 1 | 2025 | 37 | 0.240 |
Why?
|
| Birds | 1 | 2007 | 166 | 0.240 |
Why?
|
| Afferent Pathways | 1 | 2024 | 78 | 0.230 |
Why?
|
| Intellectual Disability | 2 | 2022 | 188 | 0.230 |
Why?
|
| Computer Simulation | 2 | 2025 | 1102 | 0.220 |
Why?
|
| Evoked Potentials | 2 | 2013 | 191 | 0.220 |
Why?
|
| Cadmium | 5 | 2014 | 28 | 0.220 |
Why?
|
| Albuterol | 1 | 2023 | 35 | 0.220 |
Why?
|
| Oxazines | 1 | 2023 | 13 | 0.220 |
Why?
|
| Exhalation | 1 | 2023 | 7 | 0.220 |
Why?
|
| Epinephrine | 1 | 2023 | 89 | 0.220 |
Why?
|
| Bronchodilator Agents | 1 | 2023 | 66 | 0.220 |
Why?
|
| Fentanyl | 1 | 2023 | 71 | 0.210 |
Why?
|
| Excitatory Amino Acid Antagonists | 5 | 2011 | 80 | 0.210 |
Why?
|
| Child | 8 | 2023 | 7242 | 0.210 |
Why?
|
| Receptors, Serotonin | 1 | 2002 | 34 | 0.210 |
Why?
|
| Infant | 2 | 2024 | 3189 | 0.210 |
Why?
|
| Astrocytes | 1 | 2023 | 142 | 0.210 |
Why?
|
| Circadian Rhythm | 2 | 2020 | 303 | 0.210 |
Why?
|
| Tachykinins | 1 | 2002 | 13 | 0.210 |
Why?
|
| Peripheral Nervous System | 1 | 2002 | 21 | 0.200 |
Why?
|
| Electrophysiology | 5 | 2008 | 403 | 0.200 |
Why?
|
| Gene Frequency | 1 | 2024 | 687 | 0.200 |
Why?
|
| Fever | 1 | 2003 | 127 | 0.200 |
Why?
|
| Hypoglossal Nerve | 2 | 2013 | 27 | 0.200 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2021 | 22 | 0.200 |
Why?
|
| Protein Precursors | 1 | 2002 | 140 | 0.190 |
Why?
|
| Homeodomain Proteins | 3 | 2022 | 559 | 0.190 |
Why?
|
| Sodium Channel Blockers | 5 | 2014 | 27 | 0.190 |
Why?
|
| Drug Interactions | 4 | 2011 | 244 | 0.190 |
Why?
|
| Heat-Shock Response | 1 | 2002 | 51 | 0.190 |
Why?
|
| Parkinsonian Disorders | 1 | 2021 | 21 | 0.190 |
Why?
|
| Deglutition Disorders | 1 | 2022 | 119 | 0.180 |
Why?
|
| Heat-Shock Proteins | 1 | 2002 | 183 | 0.180 |
Why?
|
| Dysautonomia, Familial | 2 | 2011 | 2 | 0.180 |
Why?
|
| Cytoskeletal Proteins | 1 | 2021 | 228 | 0.180 |
Why?
|
| Time Factors | 5 | 2016 | 5361 | 0.170 |
Why?
|
| Strychnine | 2 | 2018 | 7 | 0.170 |
Why?
|
| Potassium Channel Blockers | 2 | 2013 | 64 | 0.170 |
Why?
|
| Signal Transduction | 4 | 2023 | 3404 | 0.160 |
Why?
|
| Serotonin Antagonists | 3 | 2010 | 35 | 0.160 |
Why?
|
| Child, Preschool | 6 | 2020 | 3773 | 0.160 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 2 | 2010 | 7 | 0.160 |
Why?
|
| Lung | 1 | 2005 | 1292 | 0.160 |
Why?
|
| Cluster Analysis | 3 | 2017 | 371 | 0.150 |
Why?
|
| Vagotomy | 1 | 2018 | 12 | 0.150 |
Why?
|
| Cerebral Cortex | 3 | 2021 | 591 | 0.150 |
Why?
|
| Pyridazines | 1 | 2018 | 21 | 0.150 |
Why?
|
| Infant, Newborn | 1 | 2024 | 2497 | 0.150 |
Why?
|
| Diving | 2 | 2008 | 5 | 0.150 |
Why?
|
| Plethysmography | 2 | 2008 | 18 | 0.150 |
Why?
|
| Nonlinear Dynamics | 1 | 2018 | 73 | 0.150 |
Why?
|
| Feedback, Physiological | 1 | 2018 | 66 | 0.150 |
Why?
|
| Oxidative Stress | 1 | 2020 | 458 | 0.140 |
Why?
|
| Sleep | 1 | 2022 | 455 | 0.140 |
Why?
|
| Genetic Variation | 1 | 2024 | 1380 | 0.140 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 3 | 2011 | 14 | 0.140 |
Why?
|
| Peptides | 1 | 2021 | 649 | 0.140 |
Why?
|
| RNA | 1 | 2021 | 583 | 0.140 |
Why?
|
| Neural Stem Cells | 2 | 2018 | 58 | 0.140 |
Why?
|
| Cognition | 1 | 2022 | 580 | 0.140 |
Why?
|
| Cell Hypoxia | 2 | 2008 | 173 | 0.140 |
Why?
|
| Mice, Inbred Strains | 3 | 2012 | 308 | 0.140 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2016 | 44 | 0.130 |
Why?
|
| Mutation | 3 | 2013 | 4169 | 0.130 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2016 | 85 | 0.130 |
Why?
|
| Glutamine | 1 | 2016 | 79 | 0.130 |
Why?
|
| GABA Antagonists | 3 | 2011 | 25 | 0.130 |
Why?
|
| Cocaine | 1 | 2016 | 77 | 0.130 |
Why?
|
| Nucleus Accumbens | 1 | 2016 | 113 | 0.130 |
Why?
|
| Progesterone | 1 | 2015 | 110 | 0.130 |
Why?
|
| Encephalitis | 1 | 2015 | 104 | 0.120 |
Why?
|
| Neoplastic Stem Cells | 1 | 2017 | 162 | 0.120 |
Why?
|
| Transcription Factors | 2 | 2021 | 1665 | 0.120 |
Why?
|
| Potassium | 3 | 2004 | 258 | 0.120 |
Why?
|
| Cell Nucleus | 1 | 2017 | 602 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2016 | 1929 | 0.120 |
Why?
|
| Case-Control Studies | 3 | 2008 | 1868 | 0.120 |
Why?
|
| Glioblastoma | 1 | 2017 | 268 | 0.120 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 2 | 2011 | 15 | 0.120 |
Why?
|
| N-Methylaspartate | 2 | 2010 | 51 | 0.110 |
Why?
|
| Excitatory Amino Acid Agonists | 2 | 2010 | 45 | 0.110 |
Why?
|
| Membrane Potentials | 3 | 2005 | 436 | 0.110 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2013 | 73 | 0.110 |
Why?
|
| Phrenic Nerve | 1 | 2013 | 42 | 0.110 |
Why?
|
| Stress, Psychological | 1 | 2016 | 322 | 0.110 |
Why?
|
| KATP Channels | 1 | 2013 | 19 | 0.110 |
Why?
|
| Calcium Channels, Q-Type | 1 | 2013 | 8 | 0.110 |
Why?
|
| Calcium Channels, P-Type | 1 | 2013 | 10 | 0.110 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 56 | 0.110 |
Why?
|
| Ketanserin | 2 | 2010 | 10 | 0.110 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2018 | 107 | 0.110 |
Why?
|
| Microglia | 2 | 2015 | 108 | 0.100 |
Why?
|
| Piperazines | 2 | 2011 | 283 | 0.100 |
Why?
|
| Mitochondria | 1 | 2016 | 556 | 0.100 |
Why?
|
| Risk Factors | 2 | 2013 | 5562 | 0.100 |
Why?
|
| Integrases | 1 | 2012 | 63 | 0.100 |
Why?
|
| Picrotoxin | 1 | 2011 | 5 | 0.100 |
Why?
|
| Gap Junctions | 2 | 2017 | 144 | 0.100 |
Why?
|
| Deferoxamine | 1 | 2011 | 18 | 0.100 |
Why?
|
| Ferrous Compounds | 1 | 2011 | 17 | 0.100 |
Why?
|
| T-Box Domain Proteins | 1 | 2013 | 126 | 0.100 |
Why?
|
| Malondialdehyde | 1 | 2011 | 26 | 0.100 |
Why?
|
| Synaptic Potentials | 1 | 2011 | 15 | 0.100 |
Why?
|
| Siderophores | 1 | 2011 | 22 | 0.100 |
Why?
|
| Lipid Peroxidation | 1 | 2011 | 45 | 0.100 |
Why?
|
| Piperidines | 2 | 2010 | 163 | 0.100 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2011 | 9 | 0.090 |
Why?
|
| Cardiovascular System | 1 | 2011 | 63 | 0.090 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2011 | 4 | 0.090 |
Why?
|
| Phenanthrenes | 1 | 2011 | 3 | 0.090 |
Why?
|
| TRPM Cation Channels | 1 | 2011 | 7 | 0.090 |
Why?
|
| Egtazic Acid | 1 | 2011 | 33 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1284 | 0.090 |
Why?
|
| Motor Activity | 2 | 2016 | 327 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2017 | 784 | 0.090 |
Why?
|
| Light | 1 | 2012 | 292 | 0.090 |
Why?
|
| Chelating Agents | 1 | 2011 | 69 | 0.090 |
Why?
|
| Serotonin 5-HT2 Receptor Antagonists | 1 | 2010 | 7 | 0.090 |
Why?
|
| Isoindoles | 1 | 2010 | 14 | 0.090 |
Why?
|
| Calcium Channel Blockers | 2 | 2014 | 121 | 0.090 |
Why?
|
| Locus Coeruleus | 1 | 2010 | 6 | 0.090 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2010 | 14 | 0.090 |
Why?
|
| Anesthetics, Local | 2 | 2010 | 77 | 0.090 |
Why?
|
| Adrenergic alpha-1 Receptor Antagonists | 1 | 2010 | 8 | 0.090 |
Why?
|
| Receptors, Serotonin, 5-HT2 | 1 | 2010 | 15 | 0.090 |
Why?
|
| Microinjections | 1 | 2010 | 71 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2013 | 663 | 0.090 |
Why?
|
| Neurokinin-1 Receptor Antagonists | 1 | 2010 | 35 | 0.090 |
Why?
|
| Raphe Nuclei | 1 | 2010 | 37 | 0.090 |
Why?
|
| Electromyography | 1 | 2010 | 195 | 0.080 |
Why?
|
| Mutation, Missense | 2 | 2022 | 281 | 0.080 |
Why?
|
| Acetylcholine | 1 | 2009 | 177 | 0.080 |
Why?
|
| Dopamine | 1 | 2011 | 276 | 0.080 |
Why?
|
| Prosencephalon | 1 | 2009 | 63 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 2 | 2012 | 303 | 0.080 |
Why?
|
| Finches | 1 | 2009 | 56 | 0.080 |
Why?
|
| Biological Evolution | 1 | 2016 | 974 | 0.080 |
Why?
|
| Vocalization, Animal | 1 | 2009 | 102 | 0.080 |
Why?
|
| Regional Blood Flow | 1 | 2008 | 198 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 346 | 0.080 |
Why?
|
| Presenilin-1 | 1 | 2008 | 100 | 0.080 |
Why?
|
| Aging | 1 | 2013 | 727 | 0.080 |
Why?
|
| Hibernation | 1 | 2007 | 5 | 0.070 |
Why?
|
| Cell Survival | 2 | 2017 | 983 | 0.070 |
Why?
|
| Cerebrovascular Circulation | 1 | 2008 | 232 | 0.070 |
Why?
|
| Species Specificity | 1 | 2008 | 685 | 0.070 |
Why?
|
| Cell Membrane | 3 | 2004 | 677 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2014 | 2887 | 0.070 |
Why?
|
| Death, Sudden | 1 | 2006 | 40 | 0.070 |
Why?
|
| Respiratory System Abnormalities | 1 | 2005 | 6 | 0.070 |
Why?
|
| Stem Cells | 1 | 2008 | 376 | 0.060 |
Why?
|
| Visual Cortex | 1 | 2008 | 255 | 0.060 |
Why?
|
| Age Factors | 2 | 2013 | 1880 | 0.060 |
Why?
|
| Cadmium Chloride | 1 | 2005 | 12 | 0.060 |
Why?
|
| Tetraethylammonium | 1 | 2005 | 24 | 0.060 |
Why?
|
| Nifedipine | 1 | 2005 | 26 | 0.060 |
Why?
|
| Antiparkinson Agents | 1 | 2025 | 16 | 0.060 |
Why?
|
| Environment | 1 | 2007 | 225 | 0.060 |
Why?
|
| Adult | 1 | 2024 | 26836 | 0.060 |
Why?
|
| Cell Proliferation | 3 | 2018 | 1670 | 0.060 |
Why?
|
| Analysis of Variance | 3 | 2013 | 899 | 0.060 |
Why?
|
| Cholinergic Agents | 1 | 2024 | 17 | 0.060 |
Why?
|
| Decerebrate State | 1 | 2003 | 4 | 0.060 |
Why?
|
| Animal Experimentation | 1 | 2003 | 7 | 0.060 |
Why?
|
| Electrocardiography | 1 | 2006 | 497 | 0.060 |
Why?
|
| Alzheimer Disease | 1 | 2008 | 515 | 0.060 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2003 | 17 | 0.060 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2002 | 15 | 0.050 |
Why?
|
| Electric Conductivity | 1 | 2002 | 144 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2024 | 255 | 0.050 |
Why?
|
| KCNQ Potassium Channels | 1 | 2022 | 7 | 0.050 |
Why?
|
| Cricetulus | 1 | 2022 | 127 | 0.050 |
Why?
|
| HSC70 Heat-Shock Proteins | 1 | 2002 | 5 | 0.050 |
Why?
|
| HSP72 Heat-Shock Proteins | 1 | 2002 | 23 | 0.050 |
Why?
|
| Mice, Mutant Strains | 1 | 2002 | 231 | 0.050 |
Why?
|
| Potassium Channels | 1 | 2024 | 346 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2002 | 267 | 0.050 |
Why?
|
| Models, Biological | 1 | 2008 | 1766 | 0.050 |
Why?
|
| Temperature | 1 | 2003 | 409 | 0.050 |
Why?
|
| Cricetinae | 1 | 2022 | 558 | 0.050 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2002 | 115 | 0.050 |
Why?
|
| Reference Values | 1 | 2002 | 662 | 0.050 |
Why?
|
| Respiration, Artificial | 1 | 2003 | 358 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2002 | 301 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2021 | 340 | 0.040 |
Why?
|
| Kinetics | 1 | 2002 | 1534 | 0.040 |
Why?
|
| Monitoring, Ambulatory | 2 | 2011 | 32 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2022 | 646 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2002 | 232 | 0.040 |
Why?
|
| Genes, X-Linked | 1 | 2020 | 38 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 1008 | 0.040 |
Why?
|
| Exons | 1 | 2021 | 453 | 0.040 |
Why?
|
| Bicuculline | 2 | 2010 | 18 | 0.040 |
Why?
|
| Reactive Nitrogen Species | 1 | 2018 | 8 | 0.040 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2018 | 21 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 2018 | 59 | 0.040 |
Why?
|
| Long-Term Potentiation | 1 | 2018 | 48 | 0.040 |
Why?
|
| Neuropeptides | 1 | 2018 | 115 | 0.040 |
Why?
|
| GABA-A Receptor Antagonists | 2 | 2010 | 15 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 184 | 0.040 |
Why?
|
| Adolescent | 4 | 2011 | 9347 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2018 | 293 | 0.040 |
Why?
|
| Miniature Postsynaptic Potentials | 1 | 2016 | 6 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2021 | 757 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2016 | 82 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 247 | 0.030 |
Why?
|
| Glycine Agents | 2 | 2008 | 5 | 0.030 |
Why?
|
| Acoustic Stimulation | 1 | 2016 | 127 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2013 | 1533 | 0.030 |
Why?
|
| Bradykinin | 1 | 2014 | 46 | 0.030 |
Why?
|
| Receptors, Glutamate | 1 | 2014 | 24 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 295 | 0.030 |
Why?
|
| Ganglia, Spinal | 1 | 2014 | 75 | 0.030 |
Why?
|
| Receptors, Cholinergic | 1 | 2014 | 77 | 0.030 |
Why?
|
| Histamine | 1 | 2014 | 126 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2016 | 502 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 1497 | 0.030 |
Why?
|
| Nestin | 1 | 2013 | 18 | 0.030 |
Why?
|
| Bromodeoxyuridine | 1 | 2013 | 58 | 0.030 |
Why?
|
| Intermediate Filament Proteins | 1 | 2013 | 35 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2013 | 67 | 0.030 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2013 | 34 | 0.030 |
Why?
|
| Stem Cell Niche | 1 | 2013 | 23 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 2013 | 45 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 1983 | 0.030 |
Why?
|
| Plethysmography, Whole Body | 1 | 2012 | 9 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 223 | 0.030 |
Why?
|
| Microscopy, Video | 1 | 2012 | 34 | 0.030 |
Why?
|
| Gliosis | 1 | 2012 | 35 | 0.030 |
Why?
|
| Halorhodopsins | 1 | 2012 | 5 | 0.030 |
Why?
|
| Vestibular Nuclei | 1 | 2012 | 28 | 0.030 |
Why?
|
| Channelrhodopsins | 1 | 2012 | 7 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2012 | 73 | 0.030 |
Why?
|
| GATA3 Transcription Factor | 1 | 2012 | 48 | 0.030 |
Why?
|
| Archaeal Proteins | 1 | 2012 | 18 | 0.030 |
Why?
|
| Optics and Photonics | 1 | 2012 | 27 | 0.020 |
Why?
|
| Apnea | 1 | 2012 | 31 | 0.020 |
Why?
|
| Electrophysiological Phenomena | 1 | 2012 | 51 | 0.020 |
Why?
|
| Electroporation | 1 | 2012 | 57 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2013 | 168 | 0.020 |
Why?
|
| Rhombencephalon | 1 | 2012 | 51 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 309 | 0.020 |
Why?
|
| Cell Count | 1 | 2012 | 199 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2012 | 65 | 0.020 |
Why?
|
| Vagus Nerve | 1 | 2011 | 49 | 0.020 |
Why?
|
| Magnesium | 1 | 2012 | 178 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2012 | 313 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2012 | 144 | 0.020 |
Why?
|
| Adrenergic alpha-2 Receptor Antagonists | 1 | 2011 | 4 | 0.020 |
Why?
|
| Serotonin 5-HT2 Receptor Agonists | 1 | 2011 | 4 | 0.020 |
Why?
|
| Animals, Outbred Strains | 1 | 2011 | 17 | 0.020 |
Why?
|
| Sympathetic Nervous System | 1 | 2011 | 98 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 280 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2013 | 394 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 1452 | 0.020 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2010 | 41 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 290 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 2588 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2012 | 446 | 0.020 |
Why?
|
| Cholinergic Fibers | 1 | 2009 | 24 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 603 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 511 | 0.020 |
Why?
|
| Genetic Therapy | 1 | 2012 | 372 | 0.020 |
Why?
|
| Neurochemistry | 1 | 2009 | 2 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2009 | 27 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 3800 | 0.020 |
Why?
|
| Oxotremorine | 1 | 2008 | 4 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2008 | 96 | 0.020 |
Why?
|
| Muscarinic Agonists | 1 | 2008 | 23 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2008 | 371 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2008 | 278 | 0.020 |
Why?
|
| Social Environment | 1 | 2008 | 187 | 0.020 |
Why?
|
| Proteins | 1 | 2012 | 787 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 2331 | 0.020 |
Why?
|
| Disease Progression | 1 | 2009 | 1469 | 0.010 |
Why?
|
| Heart | 1 | 2008 | 578 | 0.010 |
Why?
|
| Lanthanum | 1 | 2004 | 16 | 0.010 |
Why?
|
| Receptors, GABA-A | 1 | 2004 | 33 | 0.010 |
Why?
|
| Cytokines | 1 | 2008 | 811 | 0.010 |
Why?
|
| Receptors, Glycine | 1 | 2004 | 11 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 8292 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2002 | 274 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2008 | 2887 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 3481 | 0.010 |
Why?
|